Cancer survivors without health insurance have greater current smoking rates
the ONA take:
Cancer survivors without health insurance have substantially greater current smoking rates than those with health insurance, a recent study published in the Journal of Cancer Survivorship: Research and Practice has shown.
For the cross-sectional study, researchers sought to examine the prevalence of current smoking, and to evaluate the association of both health insurance and access to care with smoking cessation among cancer survivors.
Researchers analyzed data from 18,896 cancer survivors who completed the 2009 Behavioral Risk Factor Surveillance System survey. Respondents were mostly 45 to 64 years of age, white, and female.
Results showed that the prevalence of current smoking was 40.9% among cancer survivors without health insurance compared with 19.5% of those with health insurance.
Researchers also found that cancer survivors with no health insurance had a 2-fold greater odds of not achieving smoking cessation versus those with health insurance.
Those who experienced health care access-related problems despite having health insurance had a 60-80% gold greater odds of not achieving smoking cessation compared with cancer survivors without access problems.
The findings suggest that "smoking cessation needs to be recognized as a crucial component of preventive care for cancer survivors."
Cancer survivors without health insurance have substantially greater current smoking rates than those with health insurance.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|